BMO Capital analyst Jeffrey Silber reiterated a Buy rating on Cross Country Healthcare (NASDAQ: CCRN) on July 10 and set a price target of $14. The company’s shares closed yesterday at $12.03.
According to TipRanks.com, Silber is a top 25 analyst with an average return of 23.7% and a 79.9% success rate. Silber covers the Services sector, focusing on stocks such as Adtalem Global Education Inc, AMN Healthcare Services Inc, and American Public Education.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cross Country Healthcare with a $13.33 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $14.65 and a one-year low of $9.07. Currently, Cross Country Healthcare has an average volume of 272K.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.
